-
Quo Vadis? The Emerging Role of the Medicines and Healthcare Products Regulatory Agency (MHRA) in an Evolving Regulatory Landscape
Sep 9, 2025, 16:22 PM -
Data Visualization of Treatment Patterns in Adults With BRAFV600E Mutant mNSCLC in Real-World Settings
Sep 9, 2025, 16:22 PM -
An Interactive R-Shiny Application for Budget Impact Modeling of Cell and Gene Therapies With Multiple Innovative Payment Scenarios
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Contemporary First-Line (1L) Treatments for Locally Advanced or Metastatic Urothelial Carcinoma La/mUC in France: A Sensitivity Analysis
Sep 9, 2025, 16:22 PM -
Faricimab vs. Aflibercept 8 mg in Patients With Neovascular Age-Related Macular Degeneration: A Cost-Utility Analysis in Italy
Sep 9, 2025, 16:22 PM -
Mapping of Treatment Patterns and Transfusion Status in Danish and Swedish Myelofibrosis (MF) Patients
Sep 9, 2025, 16:22 PM -
Evaluating the Societal and Economic Impact of Immunotherapy for Melanoma Treatment in Bulgaria
Sep 9, 2025, 16:22 PM -
Spain Leveling Up: A Comparison of Spain’s New National Health Economic Evaluation Guideline With Those of England, France, Germany, Italy, Portugal, Sweden, Ireland, Canada, Australia, and Japan
Sep 9, 2025, 16:22 PM -
Is There a Lack of Dietary Data Collection in Real-World IBD Studies? Literature Review and Future Considerations
Sep 9, 2025, 16:22 PM -
Evaluating AI Chatbot Empathy and Probing Skills in Automated Patient In-Trial Interviews: A Proof of Principle Experiment
Sep 9, 2025, 16:22 PM -
Assessment Of Parental Knowledge Information-Seeking and Information-Providing Regarding Newborn And Infant Screening Examinations
Sep 9, 2025, 16:22 PM -
Influencing Factors on the Health-Related Quality of Life of Middle-Aged and Elderly People in Ethnic Minority Areas of China: An Analysis Based on the Survey in a Urban Community of Guangxi Province
Sep 9, 2025, 16:22 PM -
Occupational Disease Claims and Payments in Indonesia: Insights From Administrative Data 2018-2022
Sep 9, 2025, 16:22 PM -
Economic Evaluations Cost and Resource Utilization in Early Triple-Negative and Low Hormone Receptor-Positive Breast Cancer: A Comprehensive Systematic Review
Sep 9, 2025, 16:22 PM -
The Role of Environmental Evidence in HTA: Comparative Insights Into Global Assessment Frameworks
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Sodium Zirconium Cyclosilicate Lokelma for Treating Hyperkalemia in Patients With Heart Failure and/or Chronic Kidney Disease in Egypt
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of Abrocitinib vs. Upadacitinib and Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
From Development to Reimbursement Evidence-Generation Strategies for HealthTech in Europe
Sep 9, 2025, 16:22 PM -
AI Models for Predicting Clinical Trial Success: Capabilities and Risks of Pattern-Driven Approaches
Sep 9, 2025, 16:22 PM -
Advancing Cost-Effectiveness Modeling With R: A Flexible Approach for HTA Submissions
Sep 9, 2025, 16:22 PM
